Percutaneous Cryoablation Treats Early-Stage Kidney Cancer
10-year disease-specific survival 94 percent; 10-year risk for hemodialysis only 2.3 percent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
10-year disease-specific survival 94 percent; 10-year risk for hemodialysis only 2.3 percent
Only registered members have full access to PracticeUpdate content.